Open AccessThe evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma
Author(s) -
Behrang Kazeminezhad,
Behdad Baradaran,
Mohammad Reza Ahmadi
Publication year - 2017
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_177_17
Subject(s) - medicine , immunohistochemistry , grading (engineering) , breast carcinoma , oncology , metastasis , pleomorphism (cytology) , lymph node metastasis , pathology , lymph node , breast cancer , cancer , civil engineering , engineering
Recently, hepatoma-derived growth factor (HDGF) has been considered as a significantly important factor in determining the prognosis and estimating the probability of tumor cell invasions, recurrence, and lymph node metastasis in different cancers, including breast malignancies.